1,2-dimethylhydrazine decreases expression ISO RGD:733171 6480464 1, 2-Dimethylhydrazine results in decreased expression of ACSL3 mRNA CTD PMID:22206623 1-benzylpiperazine increases expression EXP 6480464 N-benzylpiperazine results in increased expression of ACSL3 mRNA CTD PMID:26821219 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ACSL3 mRNA CTD PMID:30723492 1-nitropropane decreases expression EXP 6480464 1-nitropropane results in decreased expression of ACSL3 mRNA CTD PMID:17070881 17alpha-ethynylestradiol affects expression ISO RGD:733171 6480464 Ethinyl Estradiol affects the expression of ACSL3 mRNA CTD PMID:17555576 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:1602231 6480464 Metribolone promotes the reaction [NDRG1 protein binds to ACSL3 protein] CTD PMID:17220478 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:1602231 6480464 Metribolone results in increased expression of ACSL3 mRNA CTD PMID:16751804 , PMID:17010675 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1602231 6480464 Dihydrotestosterone results in increased expression of ACSL3 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:733171 6480464 2 more ... CTD PMID:20005886 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1602231 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] affects the expression of ACSL3 mRNA CTD PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733171 6480464 Tetrachlorodibenzodioxin affects the expression of ACSL3 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733171 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSL3 mRNA CTD PMID:19684285 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1602231 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSL3 mRNA CTD PMID:19684285 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ACSL3 mRNA CTD PMID:21215274 2,4-diaminotoluene increases expression EXP 6480464 2, 4-diaminotoluene results in increased expression of ACSL3 mRNA CTD PMID:17070881 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ACSL3 mRNA CTD PMID:21346803 2,6-diaminotoluene decreases expression EXP 6480464 2, 6-diaminotoluene results in decreased expression of ACSL3 mRNA CTD PMID:17070881 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of ACSL3 mRNA CTD PMID:17070881 2-nitro-p-phenylenediamine decreases expression EXP 6480464 2-nitro-4-phenylenediamine results in decreased expression of ACSL3 mRNA CTD PMID:17070881 2-nitropropane increases expression EXP 6480464 2-nitropropane results in increased expression of ACSL3 mRNA CTD PMID:17070881 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ACSL3 protein CTD PMID:34915118 4-acetylaminofluorene increases expression EXP 6480464 4-acetylaminofluorene results in increased expression of ACSL3 mRNA CTD PMID:17070881 4-hydroxyphenyl retinamide increases expression ISO RGD:733171 6480464 Fenretinide results in increased expression of ACSL3 mRNA CTD PMID:28973697 4-nitro-1,2-phenylenediamine decreases expression EXP 6480464 1, 2-diamino-4-nitrobenzene results in decreased expression of ACSL3 mRNA CTD PMID:17070881 5-aza-2'-deoxycytidine increases expression ISO RGD:1602231 6480464 Decitabine results in increased expression of ACSL3 mRNA CTD PMID:19221603 acrolein multiple interactions ISO RGD:1602231 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ACSL3 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ACSL3 mRNA CTD PMID:32699268 aflatoxin B1 decreases expression ISO RGD:733171 6480464 Aflatoxin B1 results in decreased expression of ACSL3 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1602231 6480464 Aflatoxin B1 results in increased methylation of ACSL3 intron CTD PMID:30157460 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ACSL3 mRNA CTD PMID:23630614 alpha-pinene multiple interactions ISO RGD:1602231 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ACSL3 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ACSL3 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ACSL3 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of ACSL3 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:1602231 6480464 Antirheumatic Agents results in increased expression of ACSL3 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1602231 6480464 aristolochic acid I results in decreased expression of ACSL3 mRNA CTD PMID:33212167 benzo[a]pyrene decreases expression ISO RGD:733171 6480464 Benzo(a)pyrene results in decreased expression of ACSL3 mRNA CTD PMID:19770486 , PMID:22228805 benzo[a]pyrene decreases methylation ISO RGD:1602231 6480464 Benzo(a)pyrene results in decreased methylation of ACSL3 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1602231 6480464 Benzo(a)pyrene results in decreased expression of ACSL3 mRNA CTD PMID:19221603 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1602231 6480464 7 more ... CTD PMID:19150397 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACSL3 mRNA CTD PMID:18164116 bis(2-ethylhexyl) phthalate increases expression ISO RGD:733171 6480464 Diethylhexyl Phthalate results in increased expression of ACSL3 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of ACSL3 mRNA CTD PMID:22672789 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:733171 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACSL3 mRNA] CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ACSL3 mRNA CTD PMID:25181051 bisphenol A affects expression ISO RGD:733171 6480464 bisphenol A affects the expression of ACSL3 mRNA CTD PMID:35341816 bisphenol A increases expression ISO RGD:1602231 6480464 bisphenol A results in increased expression of ACSL3 protein CTD PMID:34186270 bisphenol A decreases methylation ISO RGD:1602231 6480464 bisphenol A results in decreased methylation of ACSL3 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:733171 6480464 bisphenol A results in decreased expression of ACSL3 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ACSL3 mRNA CTD PMID:30816183 more ... bisphenol A affects expression ISO RGD:1602231 6480464 bisphenol A affects the expression of ACSL3 mRNA CTD PMID:30903817 bisphenol A affects methylation ISO RGD:733171 6480464 bisphenol A affects the methylation of ACSL3 promoter CTD PMID:27334623 Bisphenol B increases expression ISO RGD:1602231 6480464 bisphenol B results in increased expression of ACSL3 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1602231 6480464 bisphenol F results in increased expression of ACSL3 protein CTD PMID:34186270 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of ACSL3 mRNA CTD PMID:32479839 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of ACSL3 mRNA CTD PMID:24136188 caffeine increases expression ISO RGD:1602231 6480464 Caffeine results in increased expression of ACSL3 mRNA CTD PMID:11793227 calcitriol increases expression ISO RGD:1602231 6480464 Calcitriol results in increased expression of ACSL3 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1602231 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ACSL3 mRNA CTD PMID:21592394 capsaicin decreases expression ISO RGD:1602231 6480464 Capsaicin results in decreased expression of ACSL3 mRNA CTD PMID:18533110 carbamazepine affects expression ISO RGD:1602231 6480464 Carbamazepine affects the expression of ACSL3 mRNA CTD PMID:25979313 cisplatin decreases response to substance ISO RGD:1602231 6480464 ACSL3 protein results in decreased susceptibility to Cisplatin CTD PMID:16734730 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of ACSL3 mRNA CTD PMID:32741897 , PMID:33983380 cobalt dichloride increases expression ISO RGD:1602231 6480464 cobaltous chloride results in increased expression of ACSL3 mRNA CTD PMID:19376846 colforsin daropate hydrochloride increases expression ISO RGD:1602231 6480464 Colforsin results in increased expression of ACSL3 mRNA CTD PMID:16751804 copper atom multiple interactions ISO RGD:1602231 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ACSL3 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1602231 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ACSL3 mRNA CTD PMID:20971185 coumestrol decreases expression ISO RGD:1602231 6480464 Coumestrol results in decreased expression of ACSL3 mRNA CTD PMID:19167446 CU-O LINKAGE increases expression ISO RGD:1602231 6480464 cupric oxide results in increased expression of ACSL3 protein CTD PMID:25470785 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ACSL3 mRNA CTD PMID:26577399 Cuprizon multiple interactions ISO RGD:1602231 6480464 [Cuprizone co-treated with Haloperidol] results in decreased expression of ACSL3 protein CTD PMID:34122009 cycloheximide multiple interactions ISO RGD:1602231 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] affects the expression of ACSL3 mRNA CTD PMID:19684285 cyclosporin A increases expression ISO RGD:1602231 6480464 Cyclosporine results in increased expression of ACSL3 mRNA CTD PMID:20106945 , PMID:21632981 cyclosporin A affects expression ISO RGD:1602231 6480464 Cyclosporine affects the expression of ACSL3 mRNA CTD PMID:25562108 daidzein multiple interactions ISO RGD:1602231 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA CTD PMID:27424125 daidzein 7-O-beta-D-glucoside multiple interactions ISO RGD:1602231 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA CTD PMID:27424125 dichloroacetic acid increases expression ISO RGD:733171 6480464 Dichloroacetic Acid results in increased expression of ACSL3 mRNA CTD PMID:28962523 dicrotophos decreases expression ISO RGD:1602231 6480464 dicrotophos results in decreased expression of ACSL3 mRNA CTD PMID:28302478 dipentyl phthalate increases expression EXP 6480464 di-n-pentyl phthalate results in increased expression of ACSL3 mRNA CTD PMID:33983380 doxorubicin decreases expression ISO RGD:733171 6480464 Doxorubicin results in decreased expression of ACSL3 mRNA CTD PMID:26873546 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ACSL3 mRNA CTD PMID:29391264 ethanol decreases expression ISO RGD:733171 6480464 Ethanol results in decreased expression of ACSL3 mRNA CTD PMID:19167417 ethanol affects expression ISO RGD:733171 6480464 Ethanol affects the expression of ACSL3 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:733171 6480464 Ethanol results in increased expression of ACSL3 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1602231 6480464 Ethyl Methanesulfonate results in decreased expression of ACSL3 mRNA CTD PMID:23649840 etoposide affects response to substance ISO RGD:1602231 6480464 ACSL3 protein affects the susceptibility to Etoposide CTD PMID:16217747 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of ACSL3 mRNA CTD PMID:32741897 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of ACSL3 mRNA CTD PMID:18035473 fluoranthene decreases expression ISO RGD:733171 6480464 fluoranthene results in decreased expression of ACSL3 mRNA CTD PMID:28329830 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ACSL3 mRNA CTD PMID:21525395 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ACSL3 mRNA CTD PMID:24793618 formaldehyde decreases expression ISO RGD:1602231 6480464 Formaldehyde results in decreased expression of ACSL3 mRNA CTD PMID:23649840 genistein increases expression ISO RGD:1602231 6480464 Genistein results in increased expression of ACSL3 mRNA CTD PMID:18847459 genistein multiple interactions ISO RGD:1602231 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA CTD PMID:27424125 genistein 7-O-beta-D-glucoside multiple interactions ISO RGD:1602231 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA CTD PMID:27424125 glycitein multiple interactions ISO RGD:1602231 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA CTD PMID:27424125 glycitin multiple interactions ISO RGD:1602231 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA CTD PMID:27424125 graphene oxide increases expression ISO RGD:1602231 6480464 graphene oxide results in increased expression of ACSL3 protein CTD PMID:33221320 GW 4064 multiple interactions ISO RGD:1602231 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACSL3 mRNA CTD PMID:30611723 GW 4064 increases expression ISO RGD:1602231 6480464 GW 4064 results in increased expression of ACSL3 mRNA CTD PMID:30611723 GW 7647 increases expression ISO RGD:1602231 6480464 GW 7647 results in increased expression of ACSL3 mRNA CTD PMID:30611723 haloperidol multiple interactions ISO RGD:1602231 6480464 [Cuprizone co-treated with Haloperidol] results in decreased expression of ACSL3 protein CTD PMID:34122009 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of ACSL3 mRNA CTD PMID:21396975 iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of ACSL3 mRNA CTD PMID:19821111 iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of ACSL3 mRNA CTD PMID:19821111 isoflavones increases expression ISO RGD:1602231 6480464 Isoflavones results in increased expression of ACSL3 mRNA CTD PMID:16365062 isoflavones decreases expression EXP 6480464 Isoflavones results in decreased expression of ACSL3 mRNA CTD PMID:19025659 isotretinoin decreases expression ISO RGD:1602231 6480464 Isotretinoin results in decreased expression of ACSL3 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1602231 6480464 Ivermectin results in decreased expression of ACSL3 protein CTD PMID:32959892 leflunomide increases expression ISO RGD:1602231 6480464 leflunomide results in increased expression of ACSL3 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:1602231 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ACSL3 mRNA CTD PMID:26667767 manganese(II) chloride decreases expression ISO RGD:733171 6480464 manganese chloride results in decreased expression of ACSL3 mRNA CTD PMID:15295902 methyl methanesulfonate decreases expression ISO RGD:1602231 6480464 Methyl Methanesulfonate results in decreased expression of ACSL3 mRNA CTD PMID:23649840 methylseleninic acid affects expression ISO RGD:1602231 6480464 methylselenic acid affects the expression of ACSL3 mRNA CTD PMID:14617803 methylseleninic acid decreases expression ISO RGD:1602231 6480464 methylselenic acid results in decreased expression of ACSL3 mRNA CTD PMID:18548127 mitomycin C affects response to substance ISO RGD:1602231 6480464 ACSL3 protein affects the susceptibility to Mitomycin CTD PMID:16217747 mitoxantrone affects response to substance ISO RGD:1602231 6480464 ACSL3 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 monosodium L-glutamate multiple interactions ISO RGD:733171 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACSL3 mRNA CTD PMID:19001666 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of ACSL3 mRNA CTD PMID:21515302 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ACSL3 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACSL3 mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:733171 6480464 Diethylnitrosamine results in increased expression of ACSL3 mRNA CTD PMID:24535843 oleic acid multiple interactions ISO RGD:1602231 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACSL3 mRNA CTD PMID:30611723 ozone multiple interactions ISO RGD:1602231 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ACSL3 mRNA more ... CTD PMID:32699268 paracetamol increases expression ISO RGD:1602231 6480464 Acetaminophen results in increased expression of ACSL3 mRNA CTD PMID:11793227 , PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ACSL3 mRNA CTD PMID:33387578 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ACSL3 mRNA CTD PMID:32479839 paracetamol affects expression ISO RGD:1602231 6480464 Acetaminophen affects the expression of ACSL3 mRNA CTD PMID:25704631 perfluorohexanesulfonic acid increases expression ISO RGD:733171 6480464 perfluorohexanesulfonic acid results in increased expression of ACSL3 mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid affects expression ISO RGD:733171 6480464 perfluorooctane sulfonic acid affects the expression of ACSL3 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid increases expression ISO RGD:733171 6480464 perfluorooctane sulfonic acid results in increased expression of ACSL3 mRNA CTD PMID:20936131 , PMID:21705711 perfluorooctanoic acid affects expression ISO RGD:733171 6480464 perfluorooctanoic acid affects the expression of ACSL3 mRNA CTD PMID:19429403 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ACSL3 mRNA, perfluorooctanoic acid results in increased expression of ACSL3 protein CTD PMID:19162173 more ... perfluorooctanoic acid increases expression ISO RGD:733171 6480464 perfluorooctanoic acid results in increased expression of ACSL3 mRNA CTD PMID:17681415 , PMID:30657992 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of ACSL3 mRNA CTD PMID:31324951 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of ACSL3 mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:733171 6480464 Phenobarbital affects the expression of ACSL3 mRNA CTD PMID:19136022 , PMID:23091169 pirinixic acid affects expression ISO RGD:733171 6480464 pirinixic acid affects the expression of ACSL3 mRNA CTD PMID:19136022 pirinixic acid increases expression ISO RGD:733171 6480464 pirinixic acid results in increased expression of ACSL3 mRNA CTD PMID:17950772 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ACSL3 mRNA CTD PMID:19162173 more ... pirinixic acid multiple interactions ISO RGD:733171 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of ACSL3 mRNA] CTD PMID:17950772 potassium dichromate increases expression ISO RGD:1602231 6480464 Potassium Dichromate results in increased expression of ACSL3 protein CTD PMID:23718831 quinolin-8-ol decreases expression ISO RGD:1602231 6480464 Oxyquinoline results in decreased expression of ACSL3 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1602231 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ACSL3 mRNA CTD PMID:26667767 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ACSL3 mRNA CTD PMID:28374803 senecionine decreases expression ISO RGD:1602231 6480464 senecionine results in decreased expression of ACSL3 mRNA CTD PMID:26100227 sodium arsenite decreases expression ISO RGD:1602231 6480464 sodium arsenite results in decreased expression of ACSL3 mRNA CTD PMID:28595984 sodium arsenite affects expression ISO RGD:1602231 6480464 sodium arsenite affects the expression of ACSL3 mRNA CTD PMID:34032870 sodium dichromate increases expression ISO RGD:733171 6480464 sodium bichromate results in increased expression of ACSL3 mRNA CTD PMID:22561333 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of ACSL3 mRNA CTD PMID:22561333 Soman increases expression EXP 6480464 Soman results in increased expression of ACSL3 mRNA CTD PMID:19281266 sunitinib increases expression ISO RGD:1602231 6480464 Sunitinib results in increased expression of ACSL3 mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO RGD:1602231 6480464 tert-Butylhydroperoxide results in decreased expression of ACSL3 mRNA CTD PMID:15336504 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of ACSL3 mRNA CTD PMID:21515302 testosterone multiple interactions ISO RGD:1602231 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ACSL3 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1602231 6480464 Testosterone results in decreased expression of ACSL3 mRNA CTD PMID:33359661 testosterone increases expression ISO RGD:1602231 6480464 Testosterone results in increased expression of ACSL3 mRNA CTD PMID:21592394 tetrachloromethane decreases expression ISO RGD:733171 6480464 Carbon Tetrachloride results in decreased expression of ACSL3 mRNA CTD PMID:17484886 thioacetamide increases expression ISO RGD:1602231 6480464 Thioacetamide results in increased expression of ACSL3 mRNA CTD PMID:11793227 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ACSL3 mRNA CTD PMID:23411599 , PMID:34492290 topotecan affects response to substance ISO RGD:1602231 6480464 ACSL3 protein affects the susceptibility to Topotecan CTD PMID:16217747 Trapidil multiple interactions EXP 6480464 Trapidil affects the reaction [PTH protein affects the expression of ACSL3 mRNA] CTD PMID:18635661 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of ACSL3 mRNA CTD PMID:19423681 tributylstannane increases expression ISO RGD:733171 6480464 tributyltin results in increased expression of ACSL3 mRNA CTD PMID:23428407 trichostatin A increases expression ISO RGD:1602231 6480464 trichostatin A results in increased expression of ACSL3 mRNA CTD PMID:24935251 trichostatin A affects expression ISO RGD:1602231 6480464 trichostatin A affects the expression of ACSL3 mRNA CTD PMID:28542535 troglitazone decreases expression ISO RGD:733171 6480464 troglitazone results in decreased expression of ACSL3 mRNA CTD PMID:28973697 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of ACSL3 mRNA CTD PMID:21515302 urethane increases expression ISO RGD:1602231 6480464 Urethane results in increased expression of ACSL3 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1602231 6480464 Valproic Acid affects the expression of ACSL3 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1602231 6480464 Valproic Acid results in decreased expression of ACSL3 protein CTD PMID:29501571 valproic acid increases expression ISO RGD:1602231 6480464 Valproic Acid results in increased expression of ACSL3 mRNA CTD PMID:23527032 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ACSL3 mRNA CTD PMID:23034163 vorinostat increases expression ISO RGD:1602231 6480464 vorinostat results in increased expression of ACSL3 mRNA CTD PMID:22083351 zoledronic acid decreases expression ISO RGD:1602231 6480464 zoledronic acid results in decreased expression of ACSL3 protein CTD PMID:28871336
